Go Pro

Hinge Health (HNGE) Competitors

Hinge Health logo
$90.52 +0.65 (+0.72%)
As of 03:58 PM Eastern

HNGE vs. LH, DGX, GH, FMS, and BTSG

Should you buy Hinge Health stock or one of its competitors? Hinge Health's main competitors and comparable companies include Labcorp (LH), Quest Diagnostics (DGX), Guardant Health (GH), Fresenius Medical Care AG & Co. KGaA (FMS), and BrightSpring Health Services (BTSG). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Hinge Health compare to Labcorp?

Labcorp (NYSE:LH) and Hinge Health (NYSE:HNGE) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, profitability, institutional ownership, earnings and risk.

Labcorp has a beta of 0.87, meaning that its share price is 13% less volatile than the broader market. Comparatively, Hinge Health has a beta of 1.3, meaning that its share price is 30% more volatile than the broader market.

Hinge Health has a net margin of 15.15% compared to Labcorp's net margin of 6.99%. Hinge Health's return on equity of 51.60% beat Labcorp's return on equity.

Company Net Margins Return on Equity Return on Assets
Labcorp6.99% 16.74% 7.81%
Hinge Health 15.15%51.60%14.16%

Labcorp presently has a consensus target price of $330.00, indicating a potential downside of 1.77%. Hinge Health has a consensus target price of $100.57, indicating a potential upside of 11.10%. Given Hinge Health's stronger consensus rating and higher probable upside, analysts plainly believe Hinge Health is more favorable than Labcorp.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Labcorp
0 Sell rating(s)
3 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.75
Hinge Health
1 Sell rating(s)
2 Hold rating(s)
14 Buy rating(s)
1 Strong Buy rating(s)
2.83

In the previous week, Hinge Health had 2 more articles in the media than Labcorp. MarketBeat recorded 11 mentions for Hinge Health and 9 mentions for Labcorp. Labcorp's average media sentiment score of 0.82 beat Hinge Health's score of 0.79 indicating that Labcorp is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Labcorp
5 Very Positive mention(s)
1 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Hinge Health
6 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Labcorp has higher revenue and earnings than Hinge Health. Labcorp is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Labcorp$14.35B1.90$876.50M$12.0927.79
Hinge Health$587.86M12.42-$528.26M$1.2870.72

95.9% of Labcorp shares are owned by institutional investors. 0.8% of Labcorp shares are owned by insiders. Comparatively, 18.9% of Hinge Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Summary

Hinge Health beats Labcorp on 12 of the 17 factors compared between the two stocks.

How does Hinge Health compare to Quest Diagnostics?

Hinge Health (NYSE:HNGE) and Quest Diagnostics (NYSE:DGX) are both healthcare companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, profitability, media sentiment, risk, dividends, earnings and institutional ownership.

Hinge Health presently has a consensus target price of $100.57, indicating a potential upside of 11.10%. Quest Diagnostics has a consensus target price of $235.31, indicating a potential downside of 3.87%. Given Hinge Health's stronger consensus rating and higher probable upside, equities research analysts clearly believe Hinge Health is more favorable than Quest Diagnostics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hinge Health
1 Sell rating(s)
2 Hold rating(s)
14 Buy rating(s)
1 Strong Buy rating(s)
2.83
Quest Diagnostics
0 Sell rating(s)
7 Hold rating(s)
5 Buy rating(s)
1 Strong Buy rating(s)
2.54

Quest Diagnostics has higher revenue and earnings than Hinge Health. Quest Diagnostics is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hinge Health$587.86M12.42-$528.26M$1.2870.72
Quest Diagnostics$11.04B2.45$992M$9.4225.99

88.1% of Quest Diagnostics shares are held by institutional investors. 18.9% of Hinge Health shares are held by insiders. Comparatively, 0.9% of Quest Diagnostics shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Hinge Health has a beta of 1.3, indicating that its share price is 30% more volatile than the broader market. Comparatively, Quest Diagnostics has a beta of 0.56, indicating that its share price is 44% less volatile than the broader market.

Hinge Health has a net margin of 15.15% compared to Quest Diagnostics' net margin of 9.18%. Hinge Health's return on equity of 51.60% beat Quest Diagnostics' return on equity.

Company Net Margins Return on Equity Return on Assets
Hinge Health15.15% 51.60% 14.16%
Quest Diagnostics 9.18%16.01%7.27%

In the previous week, Quest Diagnostics had 24 more articles in the media than Hinge Health. MarketBeat recorded 35 mentions for Quest Diagnostics and 11 mentions for Hinge Health. Quest Diagnostics' average media sentiment score of 1.29 beat Hinge Health's score of 0.79 indicating that Quest Diagnostics is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hinge Health
6 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Quest Diagnostics
27 Very Positive mention(s)
0 Positive mention(s)
8 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Hinge Health beats Quest Diagnostics on 10 of the 16 factors compared between the two stocks.

How does Hinge Health compare to Guardant Health?

Guardant Health (NASDAQ:GH) and Hinge Health (NYSE:HNGE) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their dividends, media sentiment, valuation, risk, earnings, profitability, institutional ownership and analyst recommendations.

Guardant Health has higher revenue and earnings than Hinge Health. Guardant Health is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Guardant Health$982.02M23.36-$416.28M-$3.49N/A
Hinge Health$587.86M12.42-$528.26M$1.2870.72

Hinge Health has a net margin of 15.15% compared to Guardant Health's net margin of -38.33%. Hinge Health's return on equity of 51.60% beat Guardant Health's return on equity.

Company Net Margins Return on Equity Return on Assets
Guardant Health-38.33% N/A -25.40%
Hinge Health 15.15%51.60%14.16%

In the previous week, Guardant Health had 15 more articles in the media than Hinge Health. MarketBeat recorded 26 mentions for Guardant Health and 11 mentions for Hinge Health. Guardant Health's average media sentiment score of 1.23 beat Hinge Health's score of 0.79 indicating that Guardant Health is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Guardant Health
20 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
1 Negative mention(s)
2 Very Negative mention(s)
Positive
Hinge Health
6 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Guardant Health presently has a consensus target price of $183.78, indicating a potential upside of 7.53%. Hinge Health has a consensus target price of $100.57, indicating a potential upside of 11.10%. Given Hinge Health's higher probable upside, analysts plainly believe Hinge Health is more favorable than Guardant Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Guardant Health
1 Sell rating(s)
0 Hold rating(s)
23 Buy rating(s)
1 Strong Buy rating(s)
2.96
Hinge Health
1 Sell rating(s)
2 Hold rating(s)
14 Buy rating(s)
1 Strong Buy rating(s)
2.83

Guardant Health has a beta of 1.6, suggesting that its stock price is 60% more volatile than the broader market. Comparatively, Hinge Health has a beta of 1.3, suggesting that its stock price is 30% more volatile than the broader market.

92.6% of Guardant Health shares are owned by institutional investors. 5.6% of Guardant Health shares are owned by company insiders. Comparatively, 18.9% of Hinge Health shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Summary

Guardant Health beats Hinge Health on 9 of the 16 factors compared between the two stocks.

How does Hinge Health compare to Fresenius Medical Care AG & Co. KGaA?

Hinge Health (NYSE:HNGE) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both healthcare companies, but which is the superior business? We will compare the two companies based on the strength of their risk, profitability, dividends, media sentiment, institutional ownership, valuation, earnings and analyst recommendations.

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Hinge Health. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hinge Health$587.86M12.42-$528.26M$1.2870.72
Fresenius Medical Care AG & Co. KGaA$19.43B0.65$1.11B$1.9312.15

Hinge Health has a beta of 1.3, suggesting that its share price is 30% more volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.77, suggesting that its share price is 23% less volatile than the broader market.

Hinge Health presently has a consensus price target of $100.57, indicating a potential upside of 11.10%. Fresenius Medical Care AG & Co. KGaA has a consensus price target of $23.57, indicating a potential upside of 0.50%. Given Hinge Health's stronger consensus rating and higher possible upside, research analysts clearly believe Hinge Health is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hinge Health
1 Sell rating(s)
2 Hold rating(s)
14 Buy rating(s)
1 Strong Buy rating(s)
2.83
Fresenius Medical Care AG & Co. KGaA
5 Sell rating(s)
6 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.55

8.4% of Fresenius Medical Care AG & Co. KGaA shares are owned by institutional investors. 18.9% of Hinge Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

Hinge Health has a net margin of 15.15% compared to Fresenius Medical Care AG & Co. KGaA's net margin of 4.83%. Hinge Health's return on equity of 51.60% beat Fresenius Medical Care AG & Co. KGaA's return on equity.

Company Net Margins Return on Equity Return on Assets
Hinge Health15.15% 51.60% 14.16%
Fresenius Medical Care AG & Co. KGaA 4.83%9.28%4.16%

In the previous week, Hinge Health had 9 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 11 mentions for Hinge Health and 2 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.27 beat Hinge Health's score of 0.79 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hinge Health
6 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Fresenius Medical Care AG & Co. KGaA
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Hinge Health beats Fresenius Medical Care AG & Co. KGaA on 12 of the 17 factors compared between the two stocks.

How does Hinge Health compare to BrightSpring Health Services?

Hinge Health (NYSE:HNGE) and BrightSpring Health Services (NASDAQ:BTSG) are both healthcare companies, but which is the superior investment? We will compare the two businesses based on the strength of their earnings, media sentiment, risk, dividends, profitability, analyst recommendations, institutional ownership and valuation.

BrightSpring Health Services has higher revenue and earnings than Hinge Health. BrightSpring Health Services is trading at a lower price-to-earnings ratio than Hinge Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Hinge Health$587.86M12.42-$528.26M$1.2870.72
BrightSpring Health Services$12.91B0.94$190.67M$1.6636.96

In the previous week, BrightSpring Health Services had 3 more articles in the media than Hinge Health. MarketBeat recorded 14 mentions for BrightSpring Health Services and 11 mentions for Hinge Health. BrightSpring Health Services' average media sentiment score of 1.01 beat Hinge Health's score of 0.79 indicating that BrightSpring Health Services is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Hinge Health
6 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
BrightSpring Health Services
8 Very Positive mention(s)
1 Positive mention(s)
2 Neutral mention(s)
2 Negative mention(s)
0 Very Negative mention(s)
Positive

Hinge Health has a net margin of 15.15% compared to BrightSpring Health Services' net margin of 2.55%. Hinge Health's return on equity of 51.60% beat BrightSpring Health Services' return on equity.

Company Net Margins Return on Equity Return on Assets
Hinge Health15.15% 51.60% 14.16%
BrightSpring Health Services 2.55%16.73%5.24%

Hinge Health has a beta of 1.3, meaning that its stock price is 30% more volatile than the broader market. Comparatively, BrightSpring Health Services has a beta of 1.88, meaning that its stock price is 88% more volatile than the broader market.

Hinge Health currently has a consensus target price of $100.57, indicating a potential upside of 11.10%. BrightSpring Health Services has a consensus target price of $70.71, indicating a potential upside of 15.25%. Given BrightSpring Health Services' stronger consensus rating and higher probable upside, analysts clearly believe BrightSpring Health Services is more favorable than Hinge Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Hinge Health
1 Sell rating(s)
2 Hold rating(s)
14 Buy rating(s)
1 Strong Buy rating(s)
2.83
BrightSpring Health Services
0 Sell rating(s)
0 Hold rating(s)
18 Buy rating(s)
2 Strong Buy rating(s)
3.10

Summary

BrightSpring Health Services beats Hinge Health on 10 of the 15 factors compared between the two stocks.

Get Hinge Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for HNGE and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding HNGE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

HNGE vs. The Competition

MetricHinge HealthHealthcare Providers & Services IndustryHealthcare SectorNYSE Exchange
Market Cap$7.30B$10.05B$7.30B$24.29B
Dividend YieldN/A2.55%2.53%3.70%
P/E Ratio70.7235.29272.5530.23
Price / Sales12.425.06627.5020.01
Price / CashN/A125.5878.5732.63
Price / Book21.204.1213.157.70
Net Income-$528.26M$312.92M$3.47B$1.07B
7 Day Performance2.32%0.92%1.45%-0.16%
1 Month Performance21.98%2.28%8.72%2.89%
1 Year Performance63.54%17.43%26.12%14.61%

Hinge Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
HNGE
Hinge Health
3.8246 of 5 stars
$90.52
+0.7%
$100.57
+11.1%
+62.7%$7.30B$587.86M70.721,437
LH
Labcorp
4.1676 of 5 stars
$323.18
+1.6%
$330.00
+2.1%
+22.3%$26.21B$14.35B26.7371,000
DGX
Quest Diagnostics
4.4206 of 5 stars
$235.20
+0.3%
$235.31
+0.0%
+36.8%$25.96B$11.04B24.9757,000
GH
Guardant Health
2.7348 of 5 stars
$161.67
+2.8%
$183.78
+13.7%
+166.5%$21.70B$982.02MN/A2,506
FMS
Fresenius Medical Care AG & Co. KGaA
3.135 of 5 stars
$23.54
-1.0%
$23.57
+0.1%
-7.2%$12.64B$19.43B12.201,488

Related Companies and Tools


This page (NYSE:HNGE) was last updated on 8/26/2026 by MarketBeat.com Staff.
From Our Partners